Europe Rnai Technology Market Size & Outlook, 2025-2033
The rnai technology market in Europe is expected to reach a projected revenue of US$ 2,596.9 million by 2033. A compound annual growth rate of 13.2% is expected of Europe rnai technology market from 2025 to 2033.
- Biotechnology
- RNA analysis
- RNAi Technology Market
- RNA analysis
Revenue, 2024 (US$M)
$864.9
Forecast, 2033 (US$M)
$2,596.9
CAGR, 2025 - 2033
13.2%
Report Coverage
Europe
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the rnai technology market
Every figure cited from GVR research
Europe rnai technology market highlights
- The Europe rnai technology market generated a revenue of USD 864.9 million in 2024.
- The market is expected to grow at a CAGR of 13.2% from 2025 to 2033.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 864.9 million |
| Market revenue in 2033 | USD 2,596.9 million |
| Growth rate | 13.2% (CAGR from 2025 to 2033) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | GSK PLC, Sanofi SA, Alnylam Pharmaceuticals Inc, Arbutus Biopharma Corp, Benitec Biopharma Inc, Silence Therapeutics PLC, Ionis Pharmaceuticals Inc, Sarepta Therapeutics Inc, Percheron Therapeutics Ltd |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.5% of the global rnai technology market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,763.0 million by 2033.
No credit card required*
Publish Date: Nov 25, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
RNAi Technology Market
RNAi Technology Market segmentation & scope
RNAi Technology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| GSK PLC | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| Ionis Pharmaceuticals Inc | View profile | 927 | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 | www.ionispharma.com |
| Alnylam Pharmaceuticals Inc | View profile | 2,100 | 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA, United States, 02142 | www.alnylam.com |
| Arbutus Biopharma Corp | View profile | 73 | 701 Veterans Circle, Warminster, PA, United States, 18974 | www.arbutusbio.com |
| Benitec Biopharma Inc | View profile | 16 | 3940 Trust Way, Hayward, CA, United States, 94545 | www.benitec.com |
| Silence Therapeutics PLC | View profile | 109 | 72 Hammersmith Road, London, United Kingdom, W14 8TH | www.silence-therapeutics.com |
| Sarepta Therapeutics Inc | View profile | 1,314 | 215 First Street, Suite 415, Cambridge, MA, United States, 02142 | www.sarepta.com |
| Percheron Therapeutics Ltd | View profile | 8 | 14 Wallace Avenue, LEVEL 1, Toorak, VIC, Australia, 3142 | www.antisense.com.au |
Europe RNAi Technology Market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to RNAi Technology Market Outlook will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 74.09% in 2024.
Horizon Databook has segmented the Europe rnai technology market based on product, services covering the revenue growth of each sub-segment from 2021 to 2033.
- Europe Rnai Technology Market Product & Service Outlook (Revenue, USD Million , 2021-2033)
- Products
- Services
- Europe Rnai Technology Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug Discovery & Development
- Functional Genomics
- Others
- Europe Rnai Technology Market End-use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROs & CMOs
Reasons to subscribe to RNAi Technology Market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of RNAi Technology Market databook
- Our clientele includes a mix of RNAi Technology Market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe RNAi Technology Market, including forecasts for subscribers. This continent databook contains high-level insights into Europe RNAi Technology Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Rnai Technology Market, 2021-2033 (US$M)
Europe Product & Service - Rnai Technology Market Statistics, 2024 - 2033 (US$M)
